Trexquant Investment’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.29M | Buy |
112,464
+34,254
| +44% | +$697K | 0.03% | 840 |
|
|
2025
Q1 | $1.42M | Buy |
+78,210
| New | +$1.42M | 0.02% | 977 |
|
|
2024
Q3 | – | Sell |
-12,092
| Closed | -$448K | – | 1561 |
|
|
2024
Q2 | $448K | Sell |
12,092
-75,930
| -86% | -$2.81M | 0.01% | 1279 |
|
|
2024
Q1 | $3.69M | Buy |
88,022
+56,593
| +180% | +$2.38M | 0.07% | 417 |
|
|
2023
Q4 | $1.25M | Buy |
+31,429
| New | +$1.25M | 0.03% | 743 |
|
|
2022
Q4 | – | Sell |
-13,316
| Closed | -$374K | – | 1405 |
|
|
2022
Q3 | $374K | Buy |
+13,316
| New | +$374K | 0.01% | 932 |
|
|
2022
Q1 | – | Sell |
-8,889
| Closed | -$343K | – | 1397 |
|
|
2021
Q4 | $343K | Buy |
8,889
+1,680
| +23% | +$64.8K | 0.02% | 846 |
|
|
2021
Q3 | $389K | Buy |
+7,209
| New | +$389K | 0.03% | 635 |
|
|
2015
Q4 | – | Sell |
-14,006
| Closed | -$2.21M | – | 1042 |
|
|
2015
Q3 | $2.21M | Buy |
14,006
+11,746
| +520% | +$1.86M | 0.19% | 129 |
|
|
2015
Q2 | $854K | Sell |
2,260
-3,513
| -61% | -$1.33M | 0.1% | 391 |
|
|
2015
Q1 | $2.41M | Buy |
5,773
+1,629
| +39% | +$681K | 0.25% | 60 |
|
|
2014
Q4 | $1.13M | Buy |
+4,144
| New | +$1.13M | 0.2% | 114 |
|